ArticleAnnals of internal medicine2021

The BNT162b2 (BioNTech/Pfizer) vaccine had 95% efficacy against COVID-19 ≥7 days after the 2nd dose.

Zain ChaglaPubMed ↗Publisher ↗

No numbers read from the abstract.